All Episodes
Australian Prescriber Podcast — 224 episodes · page 1 of 3
E225 - Glaucoma management in adults: an update
E224 - High prevalence of syphilis in Australia: test, treat and trace
E223 - Rheumatic fever and rheumatic heart disease: updates for clinical practice
E222 - Acne vulgaris: a clinical update
E221 - Antibiotic prophylaxis for dental procedures: an update
E220 - The role of oral antiviral therapies for acute COVID-19
E219 - Sodium valproate: balancing benefits and risks especially in people of childbearing potential
E218 - Diagnosis and management of irritable bowel syndrome
E217 - Emergency contraception: an overview
E216 - Cardiovascular-kidney-metabolic (CKM) syndrome
E215 - Vitamin B12 deficiency: testing and treatment
E214 - Therapeutic Guidelines Kidney and Urinary
E213 - Metabolic dysfunction–associated fatty liver disease an update
E212 - Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals
E211 - Preventing infections in immunosuppressed patients
E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective?
E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
E208 - Pharmacological management of attention deficit hyperactivity disorder in adults
E207 - Injectable drugs for weight management
E206 - Testing for human immunodeficiency virus
E205 - Top 10 drugs 2024-25
E204 - Oral anticoagulation for adults with atrial fibrillation or venous thromboembolism
E203 - Pharmacological management of attention deficit hyperactivity disorder in children and adolescents
E202 - Gestational diabetes update on screening, diagnosis and maternal management
E201 - Practical guidance for stopping glucocorticoids
E200 - Therapeutic Guidelines Oral and Dental update
E199 - Aminoglycosides: an update on indications, dosing and monitoring
E198 - Choosing a nonsteroidal anti-inflammatory drug for pain
E197 - Potentially inappropriate medicines for older people
E196 - Male and female pattern hair loss
E195 - Medicines used in the treatment of opioid dependence
E194 - Using pharmacogenomics to personalise drug therapy
E193 - Therapeutic Guidelines Antibiotic Part 2
E192 - Update on long- and short-acting contraceptive methods
E191 - Psoriasis an update on topical and systemic therapies
E190 - Safe and effective use of vancomycin
E189 - Noninvasive prenatal testing: an overview
E188 - RSV: an update on prevention and management
E187 - Therapeutic Guidelines Antibiotic Part 1
E186 - Calcitonin gene-related peptide–targeted therapies for migraine
E185 - The role of triple antithrombotic therapy in patients with atrial fibrillation and coronary stent insertion
E184 - Device-assisted therapies for Parkinson disease
E183 - Drug safety in pregnancy
E182 - A national standard for people living with chronic obstructive pulmonary disease
E181 - Adverse drug reactions reporting
E180 - Diagnosis and management of antiphospholipid syndrome
E179 - Therapeutic vapes for smoking cessation and nicotine dependence
E178 – Reflections on community antimicrobial prescribing in Australia
E177 - Inhaler device selection for people with asthma or chronic obstructive pulmonary disease
E176 - Managing medicine shortages
E175 - Pharmacological management of polycystic ovary syndrome
E174 - Achieving safe medication management during transitions of care from hospital
E173 - Management of occupational exposure to blood and body fluids in primary care
E172 - Utility of common investigations for suspected inflammatory arthritis in adults
E171 - Controversies in the management of community-acquired pneumonia in adults
E170 - Quality use of medicines: who owns it now?
E169 - Deprescribing antihypertensives in frail older adults
E168 - New and emerging drug therapies for Alzheimer disease
E167 - Diagnosis and management of obstructive sleep apnoea in adults
E166 - Biologic therapies for severe asthma with persistent type 2 inflammation
E165 - Assessing, communicating and managing cardiovascular disease risk
E164 - Diagnosis and management of eosinophilic oesophagitis
E163 - Managing pre-existing diabetes prior to and during pregnancy
E162 - Management of menopause symptoms
E161 - Managing hypercholesterolaemia
E160 - Ongoing challenges of off-label prescribing
E159 - Therapeutic Guidelines Dermatology
E158 - National Medicines Policy 2.0
E157 - Top 10 drugs 2021-22 and 2022-23
E156 - Physical health monitoring for people with schizophrenia
E155 - Digital health and prescribing
E154 - An update on wound management
E153 - Blood glucose monitoring devices
E152 - Therapeutic Guidelines Diabetes
E151 - COVID-19 vaccines in 2023
E150 - COVID-19 testing: a 2023 update
E149 - Treatments for atopic dermatitis
E148 - Medicines stewardship
E147 - Therapeutic Guidelines Addiction
E146 - Medicines and children
E145 – Australian Asthma Handbook update
E144 – Therapeutic Guidelines Gastrointestinal
E143 – Treating osteoporosis
E142 – Rheumatic fever and heart disease
E141 – Polycystic kidney disease
E140 – How to manage erectile dysfunction
E139 – SGLT2 inhibitors for kidney and heart disease
E138 – Therapeutic Guidelines Sore Throat
E137 – Stepping down asthma preventer treatment
E136 – Imaging of patients with headaches
E135 - Therapeutic Guidelines Wilderness Medicine
E134 - Hormonal contraception and mood disorders
E133 – Prescribing for patients on antiretrovirals
E132 – Making guidelines better
E131 – Drugs for the management of obesity
E130 – Severe cutaneous adverse drug reactions
E129 – Home oxygen therapy
E128 – COVID-19 oral antivirals
E127 – Chronic non-cancer pain in older people
E126 - Cluster headache